Hympavzi Disease Interactions
There are 2 disease interactions with Hympavzi (marstacimab).
Moderate
Marstacimab-hncq (applies to Hympavzi) liver and renal dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Marstacimab-hncq has not been studied in patients with moderate to severe liver and renal impairment.
Moderate
Marstacimab-hncq (applies to Hympavzi) thromboembolic events
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder
Marstacimab-hncq has not been studied in patients with a history of previous thromboembolic events.
Switch to professional interaction data
Hympavzi drug interactions
There are 10 drug interactions with Hympavzi (marstacimab).
Report options
QR code containing a link to this page
More about Hympavzi (marstacimab)
- Hympavzi consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.